<DOC>
	<DOCNO>NCT01749046</DOCNO>
	<brief_summary>The purpose study determine weather Remegal fix dosage 1500 mg/daily effictive safe patient epilepsy partial seizure</brief_summary>
	<brief_title>Remegal Fixed Dose Adjunctive Therapy Patients With Partial Seizures</brief_title>
	<detailed_description>Phase III</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<criteria>Man woman , age 18 65 Diagnosis epilepsy simple and/or complex partial seizure without secondary generalization base ILAE classification Results least one prior electroencephalogram ( EEG ) magnetic resonance imaging ( MRI ) /computerized tomography scan 5 year confirm diagnostic partial seizure If seizure simple partial one , patient motor sign must enrol The onset date partial seizure accord patient 's report must least 2 year The patient must report average least 8 partial seizure per 56 day prior baseline visit The patient must seizurefree period longer 21 day 8 week prior baseline visit ( i.e V1 V2 ) Patients must treat least 2 different AEDs within last 2 year prior screen visit The patient capable would like respect protocol requirement , include available doctor 's call doctor 's appointment time , follow protocol procedures The patient agree self report seizure experience 2 visit , accurately thoroughly , diary 'll provide Patients suffer nonepileptic seizure Patients seizure ca n't count due cluster . History primary generalize seizure History status epilepticus within 12 month prior screen visit The patient receive permitted concomitant medication The patient progressive structural lesion CNS , progressive encephalopathy The patient pregnant ( plan become pregnant study ) lactate woman The patient use Remegal previously participate clinical study within 24 week prior screen visit The patient experience somatic disorder psychiatric disease condition , opinion investigator , lead health worsen influence patient ability participate actual clinical study Vulnerable patient individual majority age subject legal protection unable express consent The patient history chronic alcohol consumption drug abuse within 2 year prior screen visit The patient know history severe anaphylactic reaction severe change blood test ALT , AST , alkaline phosphatise , total bilirubin serum creatinine level â‰¥ 2 time upper limit normal range Clinically important abnormality physical examination , vital sign , ECG laboratory test result performed/obtained screen visit may interfere patient 's safety , compliance , study evaluation , accord Investigator 's opinion The patient clinically significant disease , surgical condition recent chronic consumption nonAED medication ( within 4 week prior screen visit ) might reasonably expect interfere drug absorption , distribution , metabolism , excretion QTc interval ECG perform screen visit 500 m Diseases concomitant medication may prolong QTc interval</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Epileptic seizure , Partial seizure</keyword>
</DOC>